Monthly Prescribing Reference

RECELL System Cleared for Skin Repigmentation in Patients With Vitiligo

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has approved the RECELL ® System for the treatment of vitiligo. The ...
Monthly Prescribing Reference

RECELL System Approved to Treat Full-Thickness Skin Defects

Credit: Avita Medical. The RECELL System is a single-use, autologous cell harvesting device. The Food and Drug Administration (FDA) has expanded the approval of the RECELL ® System to include ...
Nasdaq

Regional Burn Conferences Feature 12 RECELL® System Data Presentations by Prominent Burn Surgeons

VALENCIA, Calif. and MELBOURNE, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a ...
Nasdaq

RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual Meeting

VALENCIA, Calif. and MELBOURNE, Australia, Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a ...
Healio

Recell system for extensive burns approved for use in children

Please provide your email address to receive an email when new articles are posted on . The FDA has expanded its approval of the Recell system in combination with meshed autografting to include ...
Healio

Recell system under study for soft-tissue reconstruction

Please provide your email address to receive an email when new articles are posted on . Enrollment in a trial to evaluate the Recell system for soft-tissue reconstruction has been completed, according ...
WDAF-TV

AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization ...
Business Insider

RECELL® System Data Presented at American Burn Association Fall Regional Burn Conferences

Abstracts Highlighting Clinical and Health Economic Data Reinforce Effectiveness of Treatment with RECELL System More than 10,000 Patients treated with RECELL System globally VALENCIA, Calif. and ...
Business Wire

First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform ...